Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Twelve Seas Investment Company (TWLVU)
Kensington Capital Acquisition (KCAC.U)
African Gold Acquisition (AGAC.U)
Fusion Acquisition II (FSNB.U)
Mcap Acquisition (MACQU)
Silverbox Engaged Merger I (SBEAU)
Ibere Pharmaceuticals (IBERU)
Freedom Acquisition I (FACT.U)
Arya Sciences Acquisition IV (ARYD)
Warrior Technologies Acquisition Company (WARR.U)
Austerlitz Acquisition Corporation II (ASZ.U)
Austerlitz Acquisition Corporation I (AUS.U)
Leo Holdings III Corp. (LIII.U)
Upcoming IPO
Property Solutions Acquisition II (PSAGU)
Nightdragon Acquisition (NDACU)
Roblox Corporation (RBLX)
Afc Gamma, Inc. (AFCG)
Roth Ch Acquisition III (ROCRU)
Oscar Health, Inc. (OSCR)
Innovage Holding Corp (INNV)
Priced IPO
Score Media And Gaming, Inc. (SCR)
Briacell Therapeutics Corp. (BCTX)
Clip Interactive, LLC (AUDD)
Greenbox Pos (GBOX)
Virpax Pharmaceuticals, Inc. (VRPX)
Urban-gro (UGRO)
Neximmune, Inc. (NEXI)
Longeveron (LGVN)
Talis Biomedical Corporation (TLIS)
Decibel Therapeutics, Inc. (DBTX)
Loandepot, Inc. (LDI)
Bumble, Inc. (BMBL)
Apria, Inc. (APR)
Signify Health, Inc.. (SGFY)
Bioventus Inc. (BVS)
Biophytis SA (BPTS)
Vallon Pharmaceuticals (VLON)
Viant Technology Inc. (DSP)
Global Internet of People (SDH)
Baosheng Media Group Holdings (BAOS)
More companies

Cm Life Sciences II Inc. (CMIIU)

Sector - SPAC

IPO Profile

About company

They are a newly organized blank check company. While they may pursue an initial business combination target in any industry, sector or geographic region, they intend to capitalize on their management team’s background and experience to identify promising opportunities in the life sciences sector. Their team intends to leverage the strong life sciences knowledge base and public and private market experience of their sponsor with the goal of executing a successful business combination in the life sciences sector. Their sponsor is an affiliate of Eli Casdin, founder and Chief Investment Officer of Casdin Capital, and of Keith Meister, founder and Chief Investment Officer of Corvex Management, two leading investment firms. CM Life Sciences II has a focused acquisition strategy. They believe that the rise in both the number and quality of companies entering the genomics space today presages significant consolidation and restructuring. Their comprehensive understanding of the science, strong ties to the industry, and broad experience guiding public companies gives them a competitive advantage to help shape, and profit from, this key moment in the maturation of the industry.
Industry
Blank Checks
CEO CFO
Eli Casdin Brian Emes
Employees Founded
0 2020

Contacts

Address: c/o Corvex Management LP 667 Madison Avenue New York, New York 10065

Telephone: (212) 474-6745

Web page:

IPO information

Expected Date 2/23/2021
Status Priced
Exchange NYSE
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 20
Shares Revised (MM) 24
Expected offer amount (MM) $200
Realized offer amount(MM) $240

Financial Data (last reporting year)

Market Cap (MM) $290.0
Revenues (MM) $0
Net Income (Loss) (MM) $0

Voting

What do you think will happen with the CMIIU share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: Jefferies

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
Jefferies
CO-Managers
-